Immuron Limited
IMRN
$0.73
-$0.02-3.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.37M | 1.37M | 1.05M | 1.03M | 1.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37M | 1.37M | 1.05M | 1.03M | 1.30M |
| Cost of Revenue | 502.30K | 500.70K | 379.40K | 371.60K | 435.70K |
| Gross Profit | 870.90K | 868.10K | 675.20K | 661.20K | 865.70K |
| SG&A Expenses | 1.24M | 1.24M | 1.31M | 1.28M | 1.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -109.70K | -109.30K | -245.10K | -240.00K | -210.60K |
| Total Operating Expenses | 2.02M | 2.01M | 1.96M | 1.92M | 2.13M |
| Operating Income | -647.50K | -645.50K | -902.60K | -883.90K | -827.20K |
| Income Before Tax | -629.80K | -627.80K | -873.50K | -855.40K | -810.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -629.80K | -627.80K | -873.50K | -855.40K | -810.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -629.80K | -627.80K | -873.50K | -855.40K | -810.90K |
| EBIT | -647.50K | -645.50K | -902.60K | -883.90K | -827.20K |
| EBITDA | -639.40K | -637.30K | -894.60K | -876.70K | -819.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 274.03M | 274.03M | 233.35M | 233.35M | 228.53M |
| Average Diluted Shares Outstanding | 274.03M | 274.03M | 233.35M | 233.35M | 228.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |